Skip to main content
letter
. 2021 Mar 30;18(11):1917–1921. doi: 10.1513/AnnalsATS.202102-127RL

Table 2.

Characteristics of patients who experienced a major bleed

Age/Sex Invasive Mechanical Ventilation at Bleed? Vasopressors at Bleed? Site of Bleed(s) Days from tPA to Bleed Days from tPA to Death On Therapeutic Anticoagulation at Bleed? PTT at Bleed (s) INR at Bleed Platelet Count at Bleed (109/L) pRBC Units Administered* Invasive Hemostatic Intervention Performed? Fatal or Important Contributor to Death?
57/M Yes Yes NP 2 21 Yes,
enoxaparin
79 1.4 120 2 Yes No
58/M Yes No Bronchopulmonary 1 8 Yes,
heparin infusion
66 1.3 200 0 Yes No
46/M Yes Yes Bronchopulmonary and GI 0 0 No (receiving prophylactic-dose heparin) 39 1.1 205 0 No Yes
37/M Yes Yes Intracranial 6 6 Yes,
enoxaparin
32 1.4 391 0 No Yes
47/F Yes Yes NP and OP 0 19 Yes,
heparin infusion
70 1.1 149 1 No No
59/M Yes Yes Intracranial 4 4 Yes,
heparin infusion
68 1.2 138 1 No Yes

Definition of abbreviations: GI = gastrointestinal; INR = international normalized ratio; NP = nasopharyngeal; OP = oropharyngeal; pRBC = packed red blood cells; PTT = partial thromboplastin time; tPA = tissue plasminogen activator.

*

pRBC transfusion was assessed within 2 days after the bleed.